全文获取类型
收费全文 | 10081篇 |
免费 | 828篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 148篇 |
儿科学 | 215篇 |
妇产科学 | 172篇 |
基础医学 | 1288篇 |
口腔科学 | 209篇 |
临床医学 | 909篇 |
内科学 | 2059篇 |
皮肤病学 | 96篇 |
神经病学 | 961篇 |
特种医学 | 289篇 |
外科学 | 1578篇 |
综合类 | 325篇 |
一般理论 | 8篇 |
预防医学 | 1041篇 |
眼科学 | 212篇 |
药学 | 851篇 |
1篇 | |
中国医学 | 9篇 |
肿瘤学 | 554篇 |
出版年
2022年 | 59篇 |
2021年 | 144篇 |
2020年 | 94篇 |
2019年 | 144篇 |
2018年 | 199篇 |
2017年 | 146篇 |
2016年 | 141篇 |
2015年 | 173篇 |
2014年 | 275篇 |
2013年 | 441篇 |
2012年 | 638篇 |
2011年 | 658篇 |
2010年 | 388篇 |
2009年 | 393篇 |
2008年 | 762篇 |
2007年 | 800篇 |
2006年 | 766篇 |
2005年 | 723篇 |
2004年 | 752篇 |
2003年 | 643篇 |
2002年 | 651篇 |
2001年 | 96篇 |
2000年 | 44篇 |
1999年 | 99篇 |
1998年 | 122篇 |
1997年 | 128篇 |
1996年 | 106篇 |
1995年 | 95篇 |
1994年 | 86篇 |
1993年 | 65篇 |
1992年 | 49篇 |
1991年 | 48篇 |
1990年 | 37篇 |
1989年 | 49篇 |
1988年 | 46篇 |
1987年 | 31篇 |
1986年 | 51篇 |
1985年 | 51篇 |
1984年 | 55篇 |
1983年 | 66篇 |
1982年 | 83篇 |
1981年 | 76篇 |
1980年 | 62篇 |
1979年 | 35篇 |
1978年 | 46篇 |
1977年 | 31篇 |
1976年 | 45篇 |
1975年 | 29篇 |
1974年 | 24篇 |
1973年 | 32篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Shirley A. Musich Alyssa B. Schultz Wayne N. Burton Dee W. Edington 《Disease Management & Health Outcomes》2004,12(5):299-326
Corporations have engaged in sponsorship of health management programs and, more recently, disease management programs to facilitate healthy and productive work environments. The purpose of this review is to examine the health and financial outcomes from these corporate-sponsored disease management programs. This article focuses on seven diseases or chronic conditions (arthritis, asthma, cancer, depression, diabetes mellitus, heart disease, and migraine) that potentially impact employee productivity (both in time away from work and in loss of effectiveness at work) and health status including medical and pharmaceutical utilization and costs.Corporate-sponsored disease management programs typically focus on education and screening for selected diseases or chronic conditions. Partnerships have been formed with health plans and third-party program providers to reach employees with interventions and treatment. The typical outcome measures from these programs have primarily been clinical indicators and medical utilization. Measures of productivity need to be incorporated as important outcome measures for disease management programs.The estimated financial opportunity for the corporation is a reflection of the cost differential for a given disease and the prevalence of that disease within the employee population. Primary diseases, chronic conditions, and health risks contribute to increased medical utilization and decreased productivity within the corporation. Promoting programs that focus on the whole person, including health risks, chronic conditions, and diseases, will likely increase the possibility of success in helping the employee to better self-manage their health conditions and consequently provide gains for both the individual and the corporation. 相似文献
52.
53.
Elisabeth U. Dexter M.D. John M. Snider M.D. Ellen E.I. Gordon M.D. Wayne E. Richenbacher M.D. 《Journal of cardiac surgery》1997,12(6):412-415
A bstract One etiology of unilateral lobar pulmonary edema is mitral regurgitation. Echocardiography is able to demonstrate the retrograde flow of blood into the pulmonary veins and allows timely diagnosis and treatment planning. Correction of mitral regurgitation is followed by resolution of the radiographic abnormality. 相似文献
54.
Sherilyn Gross Karen Helm Jennifer J. Gruntmeir Wayne S. Stillman David W. Pyatt Richard D. Irons 《European journal of haematology》1997,59(5):318-326
Abstract: Our current understanding of human haematopoietic stem cell biology is based in part on the characterization of human CD34+ bone marrow cell differentiation in vitro. CD34 is highly expressed on early stem cells and haematopoietic progenitor cells with clonogenic potential and is gradually lost during differentiation and commitment. However, CD71 (transferrin receptor) is expressed at low levels on early stem cells and generally increases during haematopoietic progenitor cell proliferation. We reasoned that the combination of these surface markers would provide a useful framework for the simultaneous analysis of multiple lineage differentiation of CD34+ haematopoietic progenitor cells in liquid culture. In this report, we identify the phenotype of distinct subpopulations of myeloid, erythroid and lymphoid cells in liquid suspension culture using differential expression of CD34 vs. CD71 in combination with specific lineage markers. Freshly isolated human CD34+ bone marrow cells were introduced into suspension culture and monitored over a 6-d period using 3-colour flow cytometry. This is the first demonstration that differential expression of CD34 vs. CD71 can be used to simultaneously monitor differentiation of multiple haematopoietic cell lineages in liquid suspension culture, facilitating the study of cytokine-, drug- or chemical-induced alterations in haematopoietic progenitor cell differentiation in vitro. 相似文献
55.
T.Wayne Schultz 《Ecotoxicology and environmental safety》1997,38(3):336-337
56.
Wayne C. Miller PhD 《Journal of the American Dietetic Association》1994,94(12):1366-1367
57.
58.
Dr. David H. Berger MD Barry W. Feig MD Donald Podoloff MD James Norman MD C. Wayne Cruse MD Douglas S. Reintgen MD Merrick I. Ross MD 《Annals of surgical oncology》1997,4(3):247-251
Background: If cutaneous lymphoscintigraphy (CL) is accurate in predicting the draining lymph node basins at risk from primary axial
melanomas, then regional metastases should only occur in those lymph node basins identified by CL.
Methods: This study is a retrospective review of patients undergoing CL for primary axial melanomas from June 1, 1985, until June
31, 1992. Data retrieved included age, gender, number of basins identified, location of basins identified, management of basins,
recurrence in lymphatics, development of distant disease, and long-term follow-up.
Results: A total of 181 patients underwent elective LND, and 48 patients (27%) had melanoma in the nodes within the dissected basin.
Of these 181 patients, seven developed nodal metastases as their site of first recurrence. All seven recurrences were seen
at sites dissected or at sites indicated by CL, which the primary surgeon elected not to treat initially. Of the 116 patients
observed, 16 (14%) developed lymph node metastases as their first site of recurrence. Fifteen of these 16 patients had their
site of lymph node metastases predicted by CL. In this study, CL predicted 98.6% of all lymph node metastases.
Conclusions: The high overall reliability of CL as demonstrated by long-term follow-up indicates that the information obtained by CL can
be reliably used to guide intervention. Initial evaluation of patients with high-risk cutaneous melanomas at sites with ambiguous
lymphatic drainage must include CL in order to determine the draining lymph node basins and to plan therapy.
Presented at the 47th Annual Cancer Symposium of The Society of Surgical Oncology, Houston, Texas, March 17–20, 1994. 相似文献
59.
60.